After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, ...

That is concentrating on determining where the vector integrated into the chromosomes ... response in the patient that could affect their safety and efficacy. News of the pause came as UK cost ...

New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting ...

Earlier in March, the country was hit with earthquakes of magnitude 7.7 and 6.4 that had caused widespread damage and the death of more than 3500.

The diseases include dengue, chikungunya, zika and yellow fever among others. India experiences a large number of deaths due ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Williams County Vector Control District (WCVCD) will be conducting a targeted ground adulticide mosquito spray mission tonight, Tuesday, May 13, in Williston’s Spray Block 8, weather permitting.

The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

(Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial ...